FDA official: Clinical, CMC teams should be on the same page when developing CGTs
Regulatory NewsJoanne S. Eglovitch
Advanced therapies/cell and gene therapyBiologics License Application (BLA)CBERChemistry, Manufacturing and Controls (CMC)Health Authority meeting and communication strategyProduct developmentRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)